Cancer vaccines: between the idea and the reality
- PMID: 12974478
- DOI: 10.1038/nri1150
Cancer vaccines: between the idea and the reality
Abstract
Whether vaccines are designed to prepare the immune system for the encounter with a pathogen or with cancer, certain common challenges need to be faced, such as what antigen and what adjuvant to use, what type of immune response to generate and how to make it long lasting. Cancer, additionally, presents several unique hurdles. Cancer vaccines must overcome immune suppression exerted by the tumour, by previous therapy or by the effects of advanced age of the patient. If used for cancer prevention, vaccines must elicit effective long-term memory without the potential of causing autoimmunity. This article addresses the common and the unique challenges to cancer vaccines and the progress that has been made in meeting them. Considering how refractory cancer has been to standard therapy, efforts to achieve immune control of this disease are well justified.
Similar articles
-
DNA vaccines for cancer.IDrugs. 2003 Dec;6(12):1155-64. IDrugs. 2003. PMID: 14666426 Review.
-
Current developments with peptide-based human tumor vaccines.Curr Opin Oncol. 2009 Nov;21(6):524-30. doi: 10.1097/CCO.0b013e328331a78e. Curr Opin Oncol. 2009. PMID: 19770763 Review.
-
Cancer vaccines. Any future?Arch Immunol Ther Exp (Warsz). 2011 Aug;59(4):249-59. doi: 10.1007/s00005-011-0129-y. Epub 2011 Jun 5. Arch Immunol Ther Exp (Warsz). 2011. PMID: 21644030 Review.
-
Cancer vaccines: a promising cancer therapy against all odds.Future Oncol. 2007 Jun;3(3):299-306. doi: 10.2217/14796694.3.3.299. Future Oncol. 2007. PMID: 17547525 Review.
-
Tumor antigen-based immunotherapy and immunoprevention of cancer.Int Arch Allergy Immunol. 2007;142(3):179-89. doi: 10.1159/000097020. Epub 2006 Nov 13. Int Arch Allergy Immunol. 2007. PMID: 17106205 Review.
Cited by
-
Cationic Nanoparticle-Based Cancer Vaccines.Pharmaceutics. 2021 Apr 21;13(5):596. doi: 10.3390/pharmaceutics13050596. Pharmaceutics. 2021. PMID: 33919378 Free PMC article. Review.
-
Materials based tumor immunotherapy vaccines.Curr Opin Immunol. 2013 Apr;25(2):238-45. doi: 10.1016/j.coi.2012.12.008. Epub 2013 Jan 18. Curr Opin Immunol. 2013. PMID: 23337254 Free PMC article. Review.
-
Role of α-gal epitope/anti-Gal antibody reaction in immunotherapy and its clinical application in pancreatic cancer.Cancer Sci. 2013 Mar;104(3):282-90. doi: 10.1111/cas.12084. Epub 2013 Feb 6. Cancer Sci. 2013. PMID: 23240661 Free PMC article. Review.
-
Induction of effective and antigen-specific antitumour immunity by a liposomal ErbB2/HER2 peptide-based vaccination construct.Br J Cancer. 2005 Apr 25;92(8):1421-9. doi: 10.1038/sj.bjc.6602526. Br J Cancer. 2005. PMID: 15812545 Free PMC article.
-
CCL2 blockade augments cancer immunotherapy.Cancer Res. 2010 Jan 1;70(1):109-18. doi: 10.1158/0008-5472.CAN-09-2326. Epub 2009 Dec 22. Cancer Res. 2010. PMID: 20028856 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
